Larimar Therapeutics Inc — Bilancio Trimestrale (NASDAQ:LRMR) | MetaTrader

Apri il grafico completo

Notizie

2 Companies Tackling the AI Bottlenecks

William Blair conferma il rating su Larimar Therapeutics

Guggenheim conferma Buy su Larimar con target di 26$

2 Breakout Stocks to Buy Immediately

LRMR Stock on the Move: What Sparked the 55% Jump in the Past Month?

Wedbush alza il target di prezzo di Larimar Therapeutics a 12$

Wedbush raises Larimar Therapeutics stock price target to $12

Larimar Therapeutics: entità Deerfield acquistano azioni per 25 mln $

Larimar Therapeutics: Deerfield entities buy $25m in stock

Le azioni di Larimar Therapeutics scendono dell’8% dopo l’offerta da 100 milioni di dollari

Larimar Therapeutics stock falls 8% on upsized $100 million offering

Larimar Therapeutics prices $100M stock offering at $5 per share